INNOVENTRIC
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.
INNOVENTRIC
Industry:
Clinical Trials Health Care Medical Device
Founded:
2017-01-01
Address:
Ness Ziona, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.innoventric.com
Total Employee:
1+
Status:
Active
Total Funding:
16.9 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail
Current Employees Featured
David Planer Founder, CMO @ INNOVENTRIC
Founder, CMO
Amir Danino Founder & CEO @ INNOVENTRIC
Founder & CEO
2017-01-01
Rafi Benary Founder, BD @ INNOVENTRIC
Founder, BD
2017-08-01
Founder
Investors List
Horizon Capital
Horizon Capital investment in Grant - INNOVENTRIC
Official Site Inspections
http://www.innoventric.com
- Host name: 145.223.37.44
- IP address: 145.223.37.44
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "INNOVENTRIC"
About - Innoventric
Innoventric introduces a novel transcatheter approach, simplifying the complex challenge of treating tricuspid regurgitation. Our solution is designed with both the physician and patient in mind, offering a safe and effective treatment, via a …See details»
INNOVENTRIC - Crunchbase Company Profile & Funding
Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right …See details»
INNOVENTRIC - LinkedIn
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.See details»
New Prosthetic Valve Set To Transform Treatment For Common …
Nov 14, 2024 Innoventric, a startup based in Ness Ziona, Israel, is making strides in the treatment of tricuspid valve leaks, a common heart condition that can lead to serious health …See details»
Innoventric 2025 Company Profile: Valuation, Funding …
Innoventric General Information Description. Developer of percutaneous devices designed to provide treatment of tricuspid regurgitation. The company's device offers functional tricuspid valve replacement that utilizes Cross-Caval …See details»
INNOVENTRIC - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Innoventric - Overview, News & Similar companies | ZoomInfo.com
Nov 1, 2021 Israeli Medical Device Startup, Innoventric Ltd., Wins the Prestigious Horizon Europe Grant and Secures US $14M in Series A Investment NESS-ZIONA, Israel, Nov. 1, …See details»
INNOVENTRIC Company Profile, Investors, & Funding | Lucidity …
Innoventric is committed to expanding treatment beyond the traditionally treated patient population, extending care to the overlooked, ‘still forgotten’ patient population. Total …See details»
Innoventric - Company Profile - Tracxn
Mar 8, 2025 Innoventric - Developer of transcatheter solutions for patients with heart diseases. Raised a total funding of $41.8M over 4 rounds from 6 investors. Founded by Rafi Benary in …See details»
Innoventric secures $28.5 million for unique catheter …
Nov 1, 2024 Innoventric, a startup based in the Science Park in Rehovot that develops a novel catheter tricuspid valve, has announced a Series B funding round of $28.5 million led by American venture capital ...See details»
INNOVENTRIC | VentureRadar
Innoventric id developing an easy-to-use, reliable, and safe percutaneous solution for the treatment of tricuspid regurgitation. The company's Trillium device uses cross-caval anchoring …See details»
Innoventric Ltd - European Commission
Innoventric is a medtech start-up developing treatments for tricuspid valve regurgitation. The product, Trillium valve system, is a tubular stent-graft implanted/attached adjacent to the …See details»
Innoventric Secures $28.5 Million in Series B Funding for …
Oct 29, 2024 Innoventric, a pioneering Structural Heart medical device company, has successfully raised $28,500,000 in its latest funding round, marking a significant milestone in …See details»
INNOVENTRIC - Contacts, Employees, Board Members, Advisors
Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technologySee details»
Innoventric | StartupHub.ai
Feb 20, 2016 Description: Innoventric is a pioneer in transcatheter technology for treating tricuspid regurgitation (TR), focusing on a novel cross-caval approach that simplifies …See details»
Innovation - Innoventric
Innoventric's innovation is built on the firm belief that the heterotopic, cross-caval approach is key to improving TR treatment and extending care to the often-overlooked patient population. …See details»
INNOVENTRIC - Tech Stack, Apps, Patents & Trademarks
Organization. INNOVENTRIC . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 2,220. Monthly Visits …See details»
Innoventric - Alien Technology Transfer
Innoventric has developed the Trillium™ – a transcatheter tricuspid valve replacement solution. The whole procedure is minimally invasive and can be completed in 30mins. Within the EIC …See details»
25 Most Innovative Companies to Work For in 2025
1 day ago What This Company Does: Asana provides work management tools for team organization, tracking, and accountability. What Makes This Company Innovative: Asana …See details»
The best companies are the ones reinventing how they manage
Mar 14, 2025 Executives should rethink how they manage, and not just what produce, and consider whether their organization is well-placed for continuous reinvention. Leadership Why …See details»